Allister Irvine, Joanne Watt, Mary Jo Kurth, John V Lamont, Peter Fitzgerald, Mark W Ruddock
{"title":"The Importance of Diagnostics in the Treatment of Urinary Tract Infections in the United Kingdom.","authors":"Allister Irvine, Joanne Watt, Mary Jo Kurth, John V Lamont, Peter Fitzgerald, Mark W Ruddock","doi":"10.2147/RRU.S483147","DOIUrl":null,"url":null,"abstract":"<p><p>Current diagnosis of urinary tract infections (UTIs) in the UK initially relies on self-reported patient symptoms with no point-of-care test robust enough to accurately identify the causative pathogen and inform on antibiotic susceptibility. In serious UTI cases, standard urine culture is regarded as the gold standard for diagnosis and involves direct isolation, culture and antibiotic susceptibility testing of pathogens. These methods are not suitable in initial UTI diagnosis and treatment because of the time taken to conduct these analyses (≥3 days). Inaccurate and slow diagnostics can lead to unnecessary or incorrect antibiotic prescribing, which can lead to increased antimicrobial resistance and poorer patient outcomes. Novel point-of-care testing devices are urgently needed to improve the diagnostics of UTIs. In this article, we highlight novel point-of-care tests which are in development that can detect UTI-causing pathogens rapidly and accurately. These devices require additional studies to prove their clinical utilities. Adoption of these technologies can empower general practitioners (GPs) and pharmacists in prescribing decisions and improve antimicrobial stewardship.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"16 ","pages":"327-335"},"PeriodicalIF":2.0000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608548/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and Reports in Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/RRU.S483147","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Current diagnosis of urinary tract infections (UTIs) in the UK initially relies on self-reported patient symptoms with no point-of-care test robust enough to accurately identify the causative pathogen and inform on antibiotic susceptibility. In serious UTI cases, standard urine culture is regarded as the gold standard for diagnosis and involves direct isolation, culture and antibiotic susceptibility testing of pathogens. These methods are not suitable in initial UTI diagnosis and treatment because of the time taken to conduct these analyses (≥3 days). Inaccurate and slow diagnostics can lead to unnecessary or incorrect antibiotic prescribing, which can lead to increased antimicrobial resistance and poorer patient outcomes. Novel point-of-care testing devices are urgently needed to improve the diagnostics of UTIs. In this article, we highlight novel point-of-care tests which are in development that can detect UTI-causing pathogens rapidly and accurately. These devices require additional studies to prove their clinical utilities. Adoption of these technologies can empower general practitioners (GPs) and pharmacists in prescribing decisions and improve antimicrobial stewardship.
期刊介绍:
Research and Reports in Urology is an international, peer-reviewed, open access, online journal. Publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease Investigation and treatment of urological disease Pharmacology of drugs used for the treatment of urological disease Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies. Issues of patient safety and quality of care will also be considered.